Evaluation of venlafaxine on glucose homeostasis and oxidative stress in diabetic mice

Human and Experimental Toxicology

Volumn 31, Issue 12, 2012, Pages 1244-1250

  Khanam, R ^a   Najfi, H ^a   Akhtar, M ^a   Vohora, D ^a  

^a HAMDARD UNIVERSITY   (India)

Author keywords

depression; diabetes; modified forced swimming test; Venlafaxine

Indexed keywords

GLUTATHIONE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; VENLAFAXINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN LEVEL; CONTROLLED STUDY; DEPRESSION; DOSE RESPONSE; DRUG EFFECT; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; HOMEOSTASIS; IMMOBILIZATION; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; QUALITY OF LIFE; STREPTOZOCIN DIABETES;

ANIMALS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BLOOD GLUCOSE; BRAIN; CYCLOHEXANOLS; DIABETES MELLITUS, EXPERIMENTAL; GLUTATHIONE; HOMEOSTASIS; MALE; MICE; MOTOR ACTIVITY; OXIDATIVE STRESS; STREPTOZOCIN; SWIMMING; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

ANIMALIA; MUS;

EID: 84871568420     PISSN: 09603271     EISSN: 14770903     Source Type: Journal    
DOI: 10.1177/0960327112446840     Document Type: Article

References (45)

1. Katon WJ. The comorbidity of diabetes mellitus and depression. Am J Psychiat. 2008 ; 121: 736-746
2. Van den Akker M, Schuurman A, Metsemakers J, Buntinx F. Is depression related to subsequent diabetes mellitus?. Acta Psychiat Scand. 2004 ; 110 (3). 178-183
3. Brown LC, Majumdar SR, Johnson JA. Type of antidepressant therapy and risk of type 2 diabetes in people with depression. Diabetes Res Clin Pract. 2008 ; 79: 61-67
4. Katon WJ, Rutter C, Simon G, Lin EH, Ludman E, Ciechanowski P, et al. The association of comorbid depression with mortality in patients with type 2 diabetes. Diabetes Care. 2005 ; 28: 2668-2672
5. Lustman PJ, Griffith LS, Clouse RE, Freedland KE, Eisen SA, Rubin EH. Effects of nortriptyline on depression and glycemic control in diabetes: results of double blind, placebo control trial. Psychosom Med. 1997 ; 59: 241-250
6. Lin EH, Katon W, Von Korff M, Rutter C, Simon GE, Oliver M, et al. Relationship of depression and diabetes self-care, medication adherence, and preventive care. Diabetes Care. 2004 ; 27: 2154-2160
7. Derijks HJ, Meyboom RH, Heerdink ER, De Koning FH, Janknegt R, Lindquist M, et al. The association between antidepressant use and disturbances in glucose homeostasis: evidence from spontaneous reports. Eur J Clin Pharmacol. 2008 ; 64: 531-538
8. Leonard E. Effects of depression on work loss and disability bed days in individuals with diabetes. Diabetes Care. 2004 ; 27 (7). 1751-1753
9. Gomez R, Huber J, Lhullier F, Barros HM. Plasma insulin levels are increased by sertraline in rats under oral glucose overload. Braz J Med Biol Res. 2001a ; 34 (12). 1569-1572
10. Khanam R, Pillai KK. Involvement of potassium channels in hypoglycemic effect of sertraline. Indian J Exp Biol. 2006 ; 44: 120-122
11. Sansone RA, Sansone LA. Sertraline induce hyperglycemia: case report. Int J Psychiat Med. 2003 ; 33: 103-105
12. Gomez R, Huber J, Tombini G, Barros HM. Acute effect of different antidepressants on glycemia in diabetic and non-diabetic rats. Braz J Med Biol Res. 2001b ; 34 (1). 57-64
13. Goodnick PJ. Use of antidepressants in treatment of comorbid diabetes mellitus and depression as well as in diabetic neuropathy. Ann Clin Psychiat. 2001 ; 13: 31-41
14. Dhir A, Kulkarni SK. Venlafaxine reverses chronic fatigue-induced behavioral, biochemical and neurochemical alterations in mice. Pharmacol Biochem Behav. 2008 ; 89 (4). 563-571
15. Redrobe JP, Bourin M, Colombel MC, Baker GB. Dose-dependent noradrenergic and sertonergic properties of venlafaxine in animal models indicative of antidepressant activity. Psychopharmacology. 1998 ; 138: 1-8
16. Gould GG, Altamirano AV, Javors MA, Frazer A. A comparison of the chronic treatment effects of venlafaxine and other antidepressants on serotonin and norepinephrine transporters. Biol Psychiat. 2006 ; 59 (5). 408-414
17. Hellerstein DJ, Batchelder ST, Little SA, Fedak MJ, Kreditor D, Rosenthal J. Venlafaxine in the treatment of dysthymia: an open-label study. J Clin Psychiat. 1999 ; 60 (12). 845-849
18. Kodydková J, Vávrová L, Zeman M, Jirák R, Macásek J, Stanková B, et al. Antioxidative enzymes and increased oxidative stress in depressive women. Clin Biochem. 2009 ; 42: 1368-1374
19. Hakkarainen R, Partonen T, Haukka J, Virtamo J, Albanes D, Lönnqvist J. Is low dietary intake of omega-3 fatty acids associated with depression?. Am J Psychiat. 2004 ; 161: 567-569
20. Rao JS, Ertley RN, Lee HJ, DeMar JC, Arnold JT, Rapoport SI. Polyunsaturated fatty acid deprivation in rats decreases frontal cortex BDNF via a p38 MAPK-dependent mechanism. Mol Psychiat. 2006 ; 12: 36-46
21. Baydas G, Kutlu S, Naziroglu M, Canpolat S, Sandal S, Ozcan M, et al. Inhibitory effects of melatonin on lipid peroxidation induced by intracerebroventricularly administered homocysteine. J Pineal Res. 2003 ; 34: 36-39
22. Naziroǧlu M Vitamin E, new research. Braunstain MH, ed. NY, USA: Nova Science Publishers Inc ; 2006: 69-83.
23. Ozmen I, Naziroǧlu M, Alici HA, Sahin F, Cengiz M, Eren I. Spinal morphine administration reduces the fatty acid contents in spinal cord and brain by increasing oxidative stress. Neurochem Res. 2007 ; 32: 19-25
24. Eren I, Naziroǧlu M, Demirdaş A, Celik O, Uǧuz AC, Altunbaşak A. Venlafaxine modulates depression-induced oxidative stress in brain and medulla of rat. Neurochem Res. 2007 ; 32 (3). 497-505
25. Bilici M, Efe H, Köroǧlu MA, Uydu HA, Bekaroǧlu M, Deǧer O. Antioxidative enzyme activities and lipid peroxidation in major depression: alterations by antidepressant treatments. J Affect Disorder. 2001 ; 64: 43-51
26. Mahmoud AA, Zuhair BI, Khaled RA, Sami AAH, Mohamed K., Al- Essa, Jaafar A, et al. Induction of diabetes mellitus in rats using intraperitoneal streptozotocin: a comparison between 2 strains of rats. Eur J Sci Res. 2009 ; 32 (3). 398-402
27. Cryan JF, Markou A, Lucki I. Assessing antidepressant activity in rodents: recent developments and future needs. Trends Pharmacol Sci. 2002 ; 23: 238-245
28. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem. 1951 ; 193: 265-275
29. Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys. 1959 ; 82 (1). 70-77
30. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 1979 ; 95: 351-358
31. McIntyre RS, Soczynska JK, Konarski JZ, Kennedy SH. The effect of antidepressants on glucose homeostasis and insulin sensitivity: synthesis and mechanisms. Expert Opin Drug Saf. 2006 ; 5 (1). 157-168
32. de Oliveira RA, Cunha GM, Borges KD, de Bruin GS, dos Santos-Filho EA, Viana GS, et al. The effect of venlafaxine on behavior, body weight and striatal monoamine levels on sleep-deprived female rats. Pharmacol Biochem Behav. 2004 ; 79 (3). 499-506
33. De Hert M, Hanssens L, van Winkel R, Wampers M, Van Eyck D, Scheen A, et al. A case series: evaluation of the metabolic safety of aripiprazole. Schizophrenia Bull. 2007 ; 33 (3). 823-830
34. Wernicke JF, Gahimer J, Yalcin I, Wulster-Radcliffe M, Viktrup L. Safety and adverse event profile of duloxetine. Expert Opin Drug Saf. 2005 ; 4 (6). 987-993
35. McIntyre RS, Soczynska JK, Konarski JZ, Kennedy SH. The effect of antidepressants on glucose homeostasis and insulin sensitivity: synthesis and mechanisms. Expert Opin Drug Saf. 2006 ; 5 (1). 157-168
36. Weber-Hamann B, Gilles M, Schilling C, Onken V, Frankhauser P, Kopf D. Improved insulin sensitivity in 51 nondiabetic depressed inpatients remitting during antidepressive treatment with mirtazapine and venlafaxine. J Clin Psychopharmacol. 2008 ; 28 (5). 581-584
37. Meertens JH, Monteban-Kooistra WE, Ligtenberg JJ, Tulleken JE, Zijlstra JG. Severe hypoglycemia following venlafaxine intoxication: a case report. J Clin Psychopharmacol. 2007 ; 27 (4). 414-415
38. Maritim AC, Sanders RA, Watkins JB. Diabetes, oxidative stress, and antioxidants: a review. J Biochem Mol Toxicol. 2003 ; 17 (1). 24-38
39. Zafir A, Ara A, Naheed B. In vivo antioxidant status: a putative target of antidepressant action. Prog Neuro-psychopha Biol Psychiat. 2009 ; 33 (2). 220-228
40. Kumar A, Garg R, Gaur V, Kumar P. Nitric oxide mechanism in protective effect of imipramine and venlafaxine against acute immobilization stress-induced behavioral and biochemical alteration in mice. Neurosci Lett. 2009 ; 467 (2). 72-75
41. Sarandol A, Sarandol E, Eker SS, Erdinc S, Vatansever E, Kirli S. Major depressive disorder is accompanied with oxidative stress: short-term antidepressant treatment does not alter oxidative-antioxidative systems. Hum Psychopharmacol. 2007 ; 22: 67-73
42. Kang JY, Kang HJ, Chung YK, Gwag BJ, Noh JS. 5-Hydroxytryptamine attenuates free radical injury in primary mouse cortical cultures. Neuroreport. 2001 ; 12 (5). 963-966
43. Joca SR, Ferreira FR, Guimaraes FS. Modulation of stress consequences by hippocampal monoaminergic, glutamatergic and nitrergic neurotransmitter systems. Stress. 2007 ; 10: 227-249
44. Madrigal JL, Feinstein DL, Dello Russo C. Norepinephrine protects cortical neurons against microglial-induced cell death. J Neurosci Res. 2005 ; 81 (3). 390-396
45. Madrigal JL, Kalinin S, Richardson JC, Feinstein DL. Neuroprotective actions of noradrenaline: effects on glutathione synthesis and activation of peroxisome proliferator activated receptor delta. J Neurochem. 2007 ; 103 (5). 2092-2101